Talene A Yacoubian MD PhD
Movement Disorder
Professor, Neurology, University of Alabama School of Medicine
Join to view full profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Yacoubian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- John A. and Ruth R. Jurenko Endowed Professor in Neurology
Education & Training
University of Alabama Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2006 - 2007
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2005 - 2006- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2002 - 2005
- Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Nuclear Medicine, 2002 - 2005
- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2001 - 2002
Certifications & Licensure
AL State Medical License 2006 - 2026
MA State Medical License 2005 - 2007
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014-2017
Clinical Trials
- Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Publications & Presentations
PubMed
- Knockout of Rab27b exacerbates neuropathology in alpha-synuclein mouse models.Kasandra Scholz, Mary A Gannon, Lehmann Matheny, Rohma Syed, William J Stone
Acta Neuropathologica Communications. 2026-05-12 - 3 citationsPredictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3.Emilien Petit, Giulia Coarelli, David Morgan, Paulina Cunha, Hortense Hurmic
Brain. 2026-04-07 - 2 citationsTau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron loss.Jhodi M Webster, Ya-Ting Yang, Aidan T Miller, Asta Zane, Kasandra Scholz
Neurobiology of Disease. 2026-04-01
Journal Articles
- 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic Alpha-SynucleinTalene Yacoubian, MD, The Journal of Neuroscience
Press Mentions
$25,000 -- It's a Start to Battle Brain Disease and UAB Is on ItAugust 27th, 2018
APDA Funded Research Suggests New Approach to Understanding the Basic Biology of PDAugust 13th, 2018
Reduced Levels of Chaperone Protein May Have Implications for Development of Parkinson’s DiseaseAugust 10th, 2018
Grant Support
- Medical Scientist Training ProgramUNIVERSITY OF ALABAMA AT BIRMINGHAM2025–2030
- Effects of 14-3-3θ phosphorylation vesicular transport and alpha-synuclein aggregationUNIVERSITY OF ALABAMA AT BIRMINGHAM2025–2027
- Southeastern Medical Scientist SymposiumUNIVERSITY OF ALABAMA AT BIRMINGHAM2014–2027
- Role of Rab27b in synucleinopathiesUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2025
- 14-3-3 phosphorylation in Parkinson's diseaseUNIVERSITY OF ALABAMA AT BIRMINGHAM2019–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
